Ono Pharma Revenue, Profits - OPHLF Annual Income Statement

Add to My Stocks
$23.15 $0 (0%) OPHLF stock closing price Sep 21, 2018 (Closing)

Looking at financial statements, along with the Ono Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $2.19B for 2017 impacts the OPHLF stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2017 is $2.19B and has increased from $1.43B year on year as is evident when you compare the latest figures in the latest Ono Pharma profit and loss statement with those of the prior corresponding period. Also see Ono Pharma assets and Ono Pharma free cash flow for a complete valuation of OPHLF stock.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Apr - Mar201720162015201420132012201120102009
Ono Pharma Revenues or Net Sales
2.19B1.43B1.13B1.4B1.55B1.78B1.63B1.46B1.39B
Cost Of Goods Sold (COGS)585.03M370.75M292.8M321.04M361.52M353.5M---
Ono Pharma Gross Profit
1.6B1.06B838.65M1.08B1.19B1.42B---
Research & Development Expense513.44M387.22M344.55M------
Selling General & Admin Expense441.81M400.74M370.82M811.7M845.62M962.04M---
Income Before Depreciation Depletion Amortization645.38M272.38M123.28M271.62M339.58M462.24M---
Depreciation Depletion Amortization---------
Non Operating Income22.46M27.28M29.81M17.92M29.14M25.69M---
Interest Expense2.31M2.6M-------
Ono Pharma Pretax Income
665.53M297.06M152.54M288.8M368.71M487.92M---
Provision for Income Taxes165.21M72.14M42.4M87.35M109.76M187.51M---
MinorityInterest2.16M1.9M--2.35M3.33M---
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations500.32M224.92M110.13M201.45M256.59M297.08M291.83M299.76M242.52M
Extraordinary Items & Discontinued Operations---------
Ono Pharma Profit/ Loss (Net Income)
498.15M223.02M110.13M201.45M256.59M297.08M291.83M299.76M242.52M
Average Shares used to compute Diluted EPS529.95M531.02M530.06M530.61M530.16M530.51M540.43M543.05M551.18M
Average Shares used to compute Basic EPS529.95M531.02M530.06M530.61M530.16M530.51M540.43M543.05M551.18M
Income Before Nonrecurring Items498.15M223.03M108.13M199.51M256.6M297.09M291.83M299.76M242.52M
Income from Nonrecurring Items---------
Ono Pharma Earnings Per Share Basic Net
0.940.420.200.380.480.560.540.550.44
Ono Pharma Earnings Per Share Diluted Net
0.940.420.200.380.480.560.540.550.44
EPS Diluted Before Nonrecurring Items0.940.420.200.380.480.560.540.550.44
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Gilead Sciences financial analysis

The key things to look for in an income statement while doing Ono Pharma stock analysis are:

  • Topline: A growing topline, as seen from the Ono Pharma revenue chart, as is the case with Ono Pharma indicates a growing business. One needs to compare the YoY topline or sales growth of OPHLF stock with its peers like MKGAF stock and CHPTY stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $498.15M for OPHLF stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The OPHLF financials along with Ono Pharma historical stock prices provide a lot of details about the firm.

Ono Pharma Income Statement - Key Financial Ratios